Skip to main content

Inside the Market Monday’s Insider Report: CFO and COO take profits in this peaking REIT yielding 5.9%

Featured below are companies that have experienced recent insider trading activity in the public market through their direct and indirect ownerships, including accounts they have control or direction over.

The list features insider transaction activity; it does not convey total ownership information as an insider may hold numerous accounts.

Keep in mind, when looking at transaction activities by insiders, purchasing activity may reflect perceived value in a security. Selling activity may or may not be related to a stock’s valuation; perhaps an insider needs to raise money for personal reasons. An insider’s total holdings should be considered because a sale may, in context, be insignificant if this person has a large remaining position in the company. I tend to put great weight on insider transaction activity when I see multiple insiders trading a company’s shares or units.

Story continues below advertisement

Listed below are two stocks that have had recent insider buying activity.

Knight Therapeutics Inc. (GUD-T)

Between April 4 and April 10, founder, chief executive officer and director Jonathan Goodman acquired a total of 16,200 shares at an average price per share of approximately $7.40, increasing the portfolio’s holdings to 456,920 shares. The cost of these purchases totaled roughly $120,000.

Torq Resources Inc. (TORQ-X)

On April 5, Jeffrey Mason, who sits on the board of directors, invested $132,000 in shares of the company. He bought 322,000 shares at a cost per share of 41 cents, lifting his account’s holdings to 460,000 shares.

**

Listed below is a stock that has had recent selling activity reported by an insider.

Story continues below advertisement

Linamar Corp. (LNR-T)

On April 10, chief technology officer and executive vice-president of sales and marketing Mark Stoddart sold 2,000 shares at a price per share of $51.15 for an account in which he has indirect ownership, trimming this portfolio’s position to 670,017 shares. Proceeds from the sale exceeded $102,000.

**

Listed below is a security that has had mixed trading with both recent buying and selling activity reported by insiders.

H&R Real Estate Investment Trust (HR.UN-T)

Year-to-date, the unit price has rallied 16 per cent with the REIT currently yielding 5.9 per cent. The unit price is trading near a multi-year high.

Story continues below advertisement

On April 3, chief operating officer Nathan Uhr exercised his options at a price per unit of $15.42 and sold the corresponding number of units received (50,000) at a price per unit of $23.5477, eliminating this portfolio’s position. Net proceeds from the sale totaled approximately $400,000.

Between March 29 and April 2, chief financial officer Larry Froom exercised his options at a price per unit of $18.98 and sold the corresponding number of units received (38,500) at an average price per unit of approximately $23.52 for an account that he has control or direction over (The Froom Family Trust) with 121,965 units remaining in this account. Net proceeds from the sale totaled approximately $170,000.

Previously, we reported the following transactions by two insiders.

Between March 22 and March 25, chief operating officer at Primaris Management Inc. Patrick Sullivan exercised his options, receiving 35,000 units, and sold 39,000 units at an average price per unit of approximately $23.13 with 19,034 units remaining in the account. Proceeds from the sales totaled over $900,000. Primaris is a wholly owned subsidiary of H&R REIT.

On March 19, Alex Avery, who sits on the board of trustees, bought 4,000 units at a cost per unit of $22.92 on March 19, increasing his account’s position to 24,000 units. The cost of this purchase exceeded $91,000.

Report an error Editorial code of conduct
Tickers mentioned in this story
Unchecking box will stop auto data updates
Due to technical reasons, we have temporarily removed commenting from our articles. We hope to have this fixed soon. Thank you for your patience. If you are looking to give feedback on our new site, please send it along to feedback@globeandmail.com. If you want to write a letter to the editor, please forward to letters@globeandmail.com.

Welcome to The Globe and Mail’s comment community. This is a space where subscribers can engage with each other and Globe staff. Non-subscribers can read and sort comments but will not be able to engage with them in any way. Click here to subscribe.

If you would like to write a letter to the editor, please forward it to letters@globeandmail.com. Readers can also interact with The Globe on Facebook and Twitter .

Welcome to The Globe and Mail’s comment community. This is a space where subscribers can engage with each other and Globe staff. Non-subscribers can read and sort comments but will not be able to engage with them in any way. Click here to subscribe.

If you would like to write a letter to the editor, please forward it to letters@globeandmail.com. Readers can also interact with The Globe on Facebook and Twitter .

Discussion loading ...

Cannabis pro newsletter